Cognitive Behaviour Therapy and Holistic Therapy
Related Conference of Cognitive Behaviour Therapy and Holistic Therapy
September 15-16, 2025
29th International Conference on Neuropharmacology and Neurochemistry
Bangkok, Thailand
September 22-23, 2025
5th International Conference on Biomedicine & Pharmacotherapy
Amsterdam, Netherlands
November 24-25, 2025
7th World Congress on Advanced Clinical Trials and Clinical Research
Barcelona, Spain
November 24-25, 2025
4th International Forum on Pharmacovigilance and Regulatory Affairs
Barcelona, Spain
Cognitive Behaviour Therapy and Holistic Therapy Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Adaptive Trial Models - Clinical Trials Congress 2025 (Spain)
- Advanced Data Analytics - Clinical Trials Congress 2025 (Spain)
- Advanced Drug Delivery Systems - BIOMEDICINE 2025 (Netherlands)
- Advances in Omics Technologies - BIOMEDICINE 2025 (Netherlands)
- Advances in Vaccine Technology - BIOMEDICINE 2025 (Netherlands)
- Adverse Event Reporting through Mobile Health Tools - Euro Pharmacovigilance 2025 (Spain)
- AI in Clinical Research - Clinical Trials Congress 2025 (Spain)
- AI-Driven Signal Detection and Data Mining - Euro Pharmacovigilance 2025 (Spain)
- AI-Powered Pharmacovigilance - Clinical Trials Congress 2025 (Spain)
- Alzheimer’s and Parkinson’s Diseases - Neuropharmaceutics 2025 (Thailand)
- Artificial Intelligence in Biomedicine - BIOMEDICINE 2025 (Netherlands)
- Automation in Case Processing and Reporting - Euro Pharmacovigilance 2025 (Spain)
- Biotechnology in Drug Development - BIOMEDICINE 2025 (Netherlands)
- Blockchain Applications - Clinical Trials Congress 2025 (Spain)
- Blockchain Applications in Regulatory Data Integrity - Euro Pharmacovigilance 2025 (Spain)
- Brain Injury and Behavioral Neuroscience - Neuropharmaceutics 2025 (Thailand)
- Brain Pathology and Oncology Research - Neuropharmaceutics 2025 (Thailand)
- Brain Stimulation and Imaging - Neuropharmaceutics 2025 (Thailand)
- Brain Structure and Function - Neuropharmaceutics 2025 (Thailand)
- Cardiovascular Pharmacotherapy - BIOMEDICINE 2025 (Netherlands)
- Clinical Neurophysiology and Stroke - Neuropharmaceutics 2025 (Thailand)
- Clinical Pharmacology and Therapeutics - BIOMEDICINE 2025 (Netherlands)
- Clinical Supply Chain Innovation - Clinical Trials Congress 2025 (Spain)
- CNS and Brain Disorders - Neuropharmaceutics 2025 (Thailand)
- Cognitive Neuroscience and Psychology - Neuropharmaceutics 2025 (Thailand)
- Data Integrity & Compliance - Clinical Trials Congress 2025 (Spain)
- Decentralized Trials - Clinical Trials Congress 2025 (Spain)
- Digital Health and Telemedicine - BIOMEDICINE 2025 (Netherlands)
- Digital Therapeutics Trials - Clinical Trials Congress 2025 (Spain)
- Digital Transformation in Drug Safety Operations - Euro Pharmacovigilance 2025 (Spain)
- Diversity in Enrollment - Clinical Trials Congress 2025 (Spain)
- eConsent & Retention Tools - Clinical Trials Congress 2025 (Spain)
- eSource & EDC Systems - Clinical Trials Congress 2025 (Spain)
- Ethical Challenges and Regulatory Science in Healthcare and Pharmaceuticals - BIOMEDICINE 2025 (Netherlands)
- Ethics and Legal Challenges in Drug Safety Surveillance - Euro Pharmacovigilance 2025 (Spain)
- Gene Therapy and Genetic Medicine - BIOMEDICINE 2025 (Netherlands)
- Global Harmonization of Regulatory Frameworks - Euro Pharmacovigilance 2025 (Spain)
- Global Regulatory Landscape - Clinical Trials Congress 2025 (Spain)
- Global Signal Management Systems and Standards - Euro Pharmacovigilance 2025 (Spain)
- Human Brain Mapping - Neuropharmaceutics 2025 (Thailand)
- Immunotherapy and Immunopharmacology - BIOMEDICINE 2025 (Netherlands)
- Infectious Diseases and Antimicrobial Resistance - BIOMEDICINE 2025 (Netherlands)
- Innovations in Biologics and Biosimilars - BIOMEDICINE 2025 (Netherlands)
- Inspection Readiness and Audit Best Practices - Euro Pharmacovigilance 2025 (Spain)
- Integration of PV with Quality and Regulatory Affairs - Euro Pharmacovigilance 2025 (Spain)
- Managing Safety Data in Multi-Region Submissions - Euro Pharmacovigilance 2025 (Spain)
- Master Protocol Strategies - Clinical Trials Congress 2025 (Spain)
- Metabolic Disorders and Endocrinology - BIOMEDICINE 2025 (Netherlands)
- Molecular and cellular neurochemistry - Neuropharmaceutics 2025 (Thailand)
- Nanotechnology in Biomedicine - BIOMEDICINE 2025 (Netherlands)
- Neurobiology and Behaviors - Neuropharmaceutics 2025 (Thailand)
- Neurogenesis - Neuropharmaceutics 2025 (Thailand)
- Neuroimmunology and Neurological Infections - Neuropharmaceutics 2025 (Thailand)
- Neuroinformatics and Computational Neuroscience - Neuropharmaceutics 2025 (Thailand)
- Neurological Disorders and Stroke - Neuropharmaceutics 2025 (Thailand)
- Neuropharmacology and genetic aspects of CNS function - Neuropharmaceutics 2025 (Thailand)
- Neuropharmacology and Neurochemistry - Neuropharmaceutics 2025 (Thailand)
- Neuropharmacology and Neurotherapeutics - BIOMEDICINE 2025 (Netherlands)
- Neurorehabilitation and Neural Repair - Neuropharmaceutics 2025 (Thailand)
- Neuroscience and Artificial Intelligence - Neuropharmaceutics 2025 (Thailand)
- Neurotherapeutics and Case Studies - Neuropharmaceutics 2025 (Thailand)
- Oncology Research and Therapeutics - BIOMEDICINE 2025 (Netherlands)
- Paediatric and Geriatric Pharmacotherapy - BIOMEDICINE 2025 (Netherlands)
- Patient-Centric Designs - Clinical Trials Congress 2025 (Spain)
- Patient-Centric Pharmacovigilance Strategies - Euro Pharmacovigilance 2025 (Spain)
- Pharmacogenomics and Personalized Medicine - BIOMEDICINE 2025 (Netherlands)
- Pharmacovigilance and Drug Safety - BIOMEDICINE 2025 (Netherlands)
- Pharmacovigilance Compliance in Clinical Trials - Euro Pharmacovigilance 2025 (Spain)
- Pharmacovigilance in Accelerated Drug Approvals - Euro Pharmacovigilance 2025 (Spain)
- Pharmacovigilance in Gene and Cell Therapies - Euro Pharmacovigilance 2025 (Spain)
- Pharmacovigilance Outsourcing and Vendor Oversight - Euro Pharmacovigilance 2025 (Spain)
- Pre- and post-synaptic function - Neuropharmaceutics 2025 (Thailand)
- Public Health and Pharmacoeconomics - BIOMEDICINE 2025 (Netherlands)
- Rare and Orphan Diseases: Therapeutic Approaches - BIOMEDICINE 2025 (Netherlands)
- Rare Disease Therapeutics - BIOMEDICINE 2025 (Netherlands)
- Real-World Evidence in Post-Marketing Surveillance - Euro Pharmacovigilance 2025 (Spain)
- Real-World Evidence Integration - Clinical Trials Congress 2025 (Spain)
- Regenerative Medicine and Tissue Engineering - BIOMEDICINE 2025 (Netherlands)
- Respiratory and Pulmonary Pharmacotherapy - BIOMEDICINE 2025 (Netherlands)
- Risk Management Planning and Benefit-Risk Assessment - Euro Pharmacovigilance 2025 (Spain)
- Risk-Based Monitoring - Clinical Trials Congress 2025 (Spain)
- Safety Labeling Changes and Regulatory Communication - Euro Pharmacovigilance 2025 (Spain)
- Safety Monitoring of Biologics and Biosimilars - Euro Pharmacovigilance 2025 (Spain)
- Stem Cells Role in Neuro-Biological Treatment - Neuropharmaceutics 2025 (Thailand)
- Synapse formation and neurotransmitter receptors - Neuropharmaceutics 2025 (Thailand)
- Synaptic Function and Dysfunction in Brain Diseases - Neuropharmaceutics 2025 (Thailand)
- Synaptic plasticity and memory - Neuropharmaceutics 2025 (Thailand)
- Synthetic Control Arms - Clinical Trials Congress 2025 (Spain)
- Virtual Trial Platforms - Clinical Trials Congress 2025 (Spain)
- Wearables & Remote Monitoring - Clinical Trials Congress 2025 (Spain)